期刊文献+

波形蛋白、E-钙黏蛋白在原发性肝癌上皮间质转化过程中的表达及其意义 被引量:16

Expressions and significance of Vimentin and E-cadherin during epithelial-mesenchymal transition of hepatocellular carcinoma tissue
原文传递
导出
摘要 目的 探讨波形蛋白(Vimentin)、E-钙黏蛋白(E-cadherin)在原发性肝癌(HCC)的表达及其临床意义.方法 采用免疫组织化学的方法(SP法)分别检测55例HCC癌组织、癌旁组织和20例非肿瘤性正常肝组织中Vimentin及E-cadherin的表达情况,分析它们与HCC临床病理学特征的关系及对患者预后的影响.结果 Vimentin在癌组织中阳性表达率为69.1%,较癌旁组织及正常肝组织表达明显升高,差异具有统计学意义(P<0.05).E-cadherin在癌组织中阳性表达率为27.3%,较癌旁组织及正常肝组织表达明显下降,差异具有统计学意义(P<0.05).Vimentin、E-cadherin二者表达呈负相关关系(r=-0.653,P<0.05).Vimentin在TNMⅢ~Ⅳ期组、低分化组、肿瘤结节多个组、转移复发组的表达分别高于TNM Ⅰ~Ⅱ期组(χ2=7.267,P<0.05)、中高分化组(χ2=4.045,P<0.05)、肿瘤结节单个组(χ2=12.143,P<0.05)、无转移复发组(χ2=7.267,P<0.05).E-cadherin的表达在肿瘤结节单个组高于肿瘤结节多个组,差异具有统计学意义(χ2=6.878,P<0.05).随访患者表明,Vimenfin阳性表达组患者无病生存率明显低于Vimentin阴性表达组,差异具有统计学意义(P<0.05).结论 Vimentin、E-cadherin参与HCC上皮间质转化过程,Vimentin的高表达、E-cadherin的低表达与HCC的发生、发展密切相关.检测HCC患者Vimentin及E-cadherin的表达水平可协助HCC的诊断及判断预后. Objective To investigate the molecular expression and clinical significance of Vimentin and E-cadherin during epithelial-mesenchymal transformation of hepatocellular carcinoma (HCC) tissues.Methods Hepatocellular carcinoma and paracancerous tissue were collected from 55 patients,while nonneoplastic nonnal liver tissue were collected from 20 patients without cancerous diseases as control group.Expressions of Vimentin and E-cadherin were examined by immunohistochemistry staining.Clinicopathological features of the relative expression of Vimentin and E-cadherin,and its influence on prognosis were discussed as well.Results Vimentin was positively expressed in 69.1% cancer tissue,and was significantly higher than paracancerous tissues and normal liver tissues(P 〈 0.05).E-cadherin was positively expressed in 27.3% cancer tissue and was significantly lower compared with paracancerous tissues and normal liver tissues(P 〈0.05).The expression of Vimentin and E-cadherin was negatively correlated(r =-0.653,P 〈 0.05).Vimentin expressions in subgroups of TNM stage Ⅲ-Ⅳ,poor differentiation,multiple tumor nodules,metastasis and recurrence were all significantly higher than the respective subgroups as TNM stage Ⅰ-Ⅱ] (χ2 =7.267,P 〈 0.05),moderate to well differentiation (χ2 =4.045,P 〈 0.05),single tumor node (χ2=12.143,P 〈0.05),without metastasis or recurrence (χ2 =7.267,P 〈 0.05).On the contrary,Ecadherin showed higher expression in the subgroup of single tumor node compared with multiple tumor nodules(χ2 =6.878,P 〈 0.05).The follow-up of patients further demonstrated that patients with positive Vimentin expression had a significantly lower disease-free survival compared with the Vimentin negative group (P 〈0.05).Conclusions Vimentin and E-cadherin both participated in epithelial-mesenchymal transition process of hepatocellular carcinoma.High expression of Vimentin and low expression of E-cadherin were closely correlated with occurrence and development of HCC.Vimentin and E-cadherin may serve as impottant biomarkers in clinical diagnosis and prognosis prediction of HCC.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第1期9-13,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81272692)
关键词 波形蛋白 E-钙黏蛋白 原发性肝癌 上皮间质转化 Vimentin E-cadherin Hepatocellular carcinoma Epithelial-mesenchymal tran- sition(EMT)
  • 相关文献

参考文献9

  • 1Zhao Y, Yan Q, Long X, et al. Vimentin affects the mobility and invasiveness of prostate cancer cells [ J ]. Cell Biochem Funct, 2008,26(5 ) :571-577.
  • 2陈静,刘文斌,荚卫东,许戈良,马金良,李建生.热休克蛋白75在肝癌细胞株中的表达及其在上皮间质转化中的作用[J].中华肝胆外科杂志,2014,20(1):51-55. 被引量:5
  • 3Wheelk M J, Johnson KR. Cadherins as modulators of cellular phenotype [ J ]. Annu Rev Cell Dev Biol, 2003,19 (8) :207-235.
  • 4Gassmann P, Enns A, Haler J. Role of tumor cell adhesion and migratian in organ-specific metastasis formation [ J ]. Onkologie, 2004,27(6) :577-582.
  • 5陈徐艰,沈亦钰,王兢,钟征翔,潘红佳.异黏蛋白、上皮钙黏蛋白、β链蛋白在肝细胞癌中的表达及预后研究[J].中华肝胆外科杂志,2013,19(8):597-600. 被引量:6
  • 6Lim SC, Lee MS. Significance of E-cadherin/beta-catenin com- plex and cyclin D1 in breast cancer[ J ]. Oncol Rep, 2002,9(5 ) : 915-928.
  • 7Pecina-Slaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells[J]. Cancer Cell lnt, 2003,3( 1 ) :17.
  • 8Sun Y, Song GD, Sun N, et al. Slug overexpression induces stem- ness and promotes hepatocellular carcinoma cell invasion and me- tastasis [ J ]. Oncol Lett, 2014,7 ( 6 ) : 1936-1940.
  • 9Feng Li,Benjamin Tiede,Joan Massague,Yibin Kang.Beyond tumorigenesis: cancer stem cells in metastasis[J].Cell Research,2007,17(1):3-14. 被引量:86

二级参考文献155

  • 1Bernards R. Cancer: cues for migration. Nature 2003; 425:247-248.
  • 2Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459-469.
  • 3Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
  • 4John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23.
  • 5Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835.
  • 6Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol2005; 25:8581-8591.
  • 7Chinni SR, Sivalogan S, Dong Z, et al. CXCL 12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Prostate 2006; 66:32-48.
  • 8Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109:625-637.
  • 9Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 2000; 28:1274-1285.
  • 10Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112:160-169.

共引文献94

同被引文献129

引证文献16

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部